Analyze Diet
Cancer research2005; 65(20); 9206-9215; doi: 10.1158/0008-5472.CAN-05-1024

Misregulated Wnt/beta-catenin signaling leads to ovarian granulosa cell tumor development.

Abstract: Misregulation of the Wnt/beta-catenin signaling pathway is a hallmark of several forms of cancer. Components of the Wnt/beta-catenin pathway are expressed in ovarian granulosa cells; nevertheless, its potential involvement in granulosa cell tumorigenesis has not been examined. To this end, human (n = 6) and equine (n = 18) granulosa cell tumors (GCT) were analyzed for beta-catenin expression by immunohistochemistry. Unlike granulosa cells of normal ovaries, most (15 of 24) GCT samples showed nuclear localization of beta-catenin, suggesting that activation of the Wnt/beta-catenin pathway plays a role in the etiology of GCT. To confirm this hypothesis, Catnb(flox(ex3)/+); Amhr2(cre/+) mice that express a dominant stable beta-catenin mutant in their granulosa cells were generated. These mice developed follicle-like structures containing disorganized, pleiomorphic granulosa by 6 weeks of age. Even in older mice, these follicle-like lesions grew no larger than the size of antral follicles and contained very few proliferating cells. Similar to corpora lutea, the lesions were highly vascularized, although they did not express the luteinization marker Cyp11a1. Catnb(flox(ex3)/+); Amhr2(cre/+) females were also found to be severely subfertile, and fewer corpora lutea were found to form in response to exogenous gonadotropin compared with control mice. In older mice, the ovarian lesions often evolved into GCT, indicating that they represent a pretumoral intermediate stage. The GCT in Catnb(flox(ex3)/+); Amhr2(cre/+) mice featured many histopathologic similarities to the human disease, and prevalence of tumor development attained 57% at 7.5 months of age. Together, these studies show a causal link between misregulated Wnt/beta-catenin signaling and GCT development and provide a novel model system for the study of GCT biology.
Publication Date: 2005-10-19 PubMed ID: 16230381DOI: 10.1158/0008-5472.CAN-05-1024Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article demonstrates a link between improper regulation of the Wnt/beta-catenin signaling pathway and the development of ovarian granulosa cell tumors.

Study Background

  • The Wnt/beta-catenin signaling pathway plays a crucial role in cell growth and division (proliferation), renewal and survival. Its misregulation often induces various types of cancer. Even though components of the pathway are expressed in ovarian granulosa cells, previous research had not explored its involvement in granulosa cell tumorigenesis.

Objective and Methodology

  • The researchers sought to understand the pathway’s potential role in the development of granulosa cell tumors (GCT), by analyzing the beta-catenin expression of human (6 samples) and equine (18 samples) GCTs through immunohistochemistry.

Results

  • Unlike normal granulosa cells, majority of the GCT samples exhibited nuclear localization of beta-catenin, implying that activation of the Wnt/beta-catenin pathway might influence GCT development.
  • To verify this, researchers generated mice strain, Catnb(flox(ex3)/+); Amhr2(cre/+), with a stably expressed dominant beta-catenin mutant in their granulosa cells. The mice developed follicle-like structures containing disorganized granulosa by six weeks of age.
  • These mutations led to abnormalities such as severely reduced fertility, fewer corpora lutea formed in response to exogenous gonadotropin, disorganized granulosa cells, and eventually granulosa cell tumors.
  • The tumors developed in the experimental mice displayed many histopathologic similarities to human GCT, confirming a potential relevance to human ovarian health.

Conclusion

  • The study concluded that misregulated Wnt/beta-catenin signaling contributes significantly to GCT development. It also provided a new model for studying GCT biology, thereby offering potential for further research and treatment strategies.

Cite This Article

APA
Boerboom D, Paquet M, Hsieh M, Liu J, Jamin SP, Behringer RR, Sirois J, Taketo MM, Richards JS. (2005). Misregulated Wnt/beta-catenin signaling leads to ovarian granulosa cell tumor development. Cancer Res, 65(20), 9206-9215. https://doi.org/10.1158/0008-5472.CAN-05-1024

Publication

ISSN: 0008-5472
NlmUniqueID: 2984705R
Country: United States
Language: English
Volume: 65
Issue: 20
Pages: 9206-9215

Researcher Affiliations

Boerboom, Derek
  • Department of Molecular and Cellular Biology and Center for Comparative Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Paquet, Marilene
    Hsieh, Minnie
      Liu, Jinsong
        Jamin, Soazik P
          Behringer, Richard R
            Sirois, Jean
              Taketo, Makoto M
                Richards, Joanne S

                  MeSH Terms

                  • Animals
                  • Disease Models, Animal
                  • Female
                  • Granulosa Cell Tumor / genetics
                  • Granulosa Cell Tumor / metabolism
                  • Granulosa Cell Tumor / pathology
                  • Horses
                  • Humans
                  • Immunohistochemistry
                  • Mice
                  • Mice, Transgenic
                  • Ovarian Neoplasms / genetics
                  • Ovarian Neoplasms / metabolism
                  • Ovarian Neoplasms / pathology
                  • Receptors, Peptide / genetics
                  • Receptors, Transforming Growth Factor beta
                  • Signal Transduction
                  • Wnt Proteins / biosynthesis
                  • Wnt Proteins / genetics
                  • beta Catenin / biosynthesis
                  • beta Catenin / genetics

                  Citations

                  This article has been cited 78 times.
                  1. Jung D, Almstedt K, Battista MJ, Seeger A, Jäkel J, Brenner W, Hasenburg A. Immunohistochemical markers of prognosis in adult granulosa cell tumors of the ovary - a review. J Ovarian Res 2023 Mar 3;16(1):50.
                    doi: 10.1186/s13048-023-01125-1pubmed: 36869369google scholar: lookup
                  2. Bridges K, Yao HH, Nicol B. Loss of Runx1 Induces Granulosa Cell Defects and Development of Ovarian Tumors in the Mouse. Int J Mol Sci 2022 Nov 21;23(22).
                    doi: 10.3390/ijms232214442pubmed: 36430923google scholar: lookup
                  3. Ni N, Fang X, Mullens DA, Cai JJ, Ivanov I, Bartholin L, Li Q. Transcriptomic Profiling of Gene Expression Associated with Granulosa Cell Tumor Development in a Mouse Model. Cancers (Basel) 2022 Apr 27;14(9).
                    doi: 10.3390/cancers14092184pubmed: 35565312google scholar: lookup
                  4. Cheng J, Liu Y. Knockout of cyclin B1 in granulosa cells causes female subfertility. Cell Cycle 2022 Sep;21(17):1867-1878.
                    doi: 10.1080/15384101.2022.2074740pubmed: 35536551google scholar: lookup
                  5. Roy S, Sinha N, Huang B, Cline-Fedewa H, Gleicher N, Wang J, Sen A. Jumonji Domain-containing Protein-3 (JMJD3/Kdm6b) Is Critical for Normal Ovarian Function and Female Fertility. Endocrinology 2022 May 1;163(5).
                    doi: 10.1210/endocr/bqac047pubmed: 35396990google scholar: lookup
                  6. Habara O, Logan CY, Kanai-Azuma M, Nusse R, Takase HM. WNT signaling in pre-granulosa cells is required for ovarian folliculogenesis and female fertility. Development 2021 May 1;148(9).
                    doi: 10.1242/dev.198846pubmed: 33914868google scholar: lookup
                  7. Cheng J, Li Y, Zhang Y, Wang X, Sun F, Liu Y. Conditional deletion of Wntless in granulosa cells causes impaired corpora lutea formation and subfertility. Aging (Albany NY) 2020 Dec 3;13(1):1001-1016.
                    doi: 10.18632/aging.202222pubmed: 33291079google scholar: lookup
                  8. Fang X, Li Q. New insights into testicular granulosa cell tumors. Oncol Lett 2020 Dec;20(6):293.
                    doi: 10.3892/ol.2020.12156pubmed: 33101487google scholar: lookup
                  9. Zhu H, Qin N, Xu X, Sun X, Chen X, Zhao J, Xu R, Mishra B. Synergistic inhibition of csal1 and csal3 in granulosa cell proliferation and steroidogenesis of hen ovarian prehierarchical development†. Biol Reprod 2019 Nov 21;101(5):986-1000.
                    doi: 10.1093/biolre/ioz137pubmed: 31350846google scholar: lookup
                  10. Mohamed NE, Hay T, Reed KR, Smalley MJ, Clarke AR. APC2 is critical for ovarian WNT signalling control, fertility and tumour suppression. BMC Cancer 2019 Jul 10;19(1):677.
                    doi: 10.1186/s12885-019-5867-ypubmed: 31291912google scholar: lookup
                  11. Tsoi M, Morin M, Rico C, Johnson RL, Paquet M, Gévry N, Boerboom D. Lats1 and Lats2 are required for ovarian granulosa cell fate maintenance. FASEB J 2019 Oct;33(10):10819-10832.
                    doi: 10.1096/fj.201900609Rpubmed: 31268774google scholar: lookup
                  12. Tu J, Cheung HH, Lu G, Chan CL, Chen Z, Chan WY. microRNA-126 Is a Tumor Suppressor of Granulosa Cell Tumor Mediated by Its Host Gene EGFL7. Front Oncol 2019;9:486.
                    doi: 10.3389/fonc.2019.00486pubmed: 31245291google scholar: lookup
                  13. Martinez RM, Baccarelli AA, Liang L, Dioni L, Mansur A, Adir M, Bollati V, Racowsky C, Hauser R, Machtinger R. Body mass index in relation to extracellular vesicle-linked microRNAs in human follicular fluid. Fertil Steril 2019 Aug;112(2):387-396.e3.
                  14. Richards JS. WOMEN IN REPRODUCTIVE SCIENCE: Discovering science and the ovary: a career of joy. Reproduction 2019 Dec;158(6):F69-F80.
                    doi: 10.1530/REP-18-0513pubmed: 30780130google scholar: lookup
                  15. Martinez RM, Liang L, Racowsky C, Dioni L, Mansur A, Adir M, Bollati V, Baccarelli AA, Hauser R, Machtinger R. Extracellular microRNAs profile in human follicular fluid and IVF outcomes. Sci Rep 2018 Nov 19;8(1):17036.
                    doi: 10.1038/s41598-018-35379-3pubmed: 30451969google scholar: lookup
                  16. Tu J, Cheung HH, Lu G, Chen Z, Chan WY. MicroRNA-10a promotes granulosa cells tumor development via PTEN-AKT/Wnt regulatory axis. Cell Death Dis 2018 Oct 22;9(11):1076.
                    doi: 10.1038/s41419-018-1117-5pubmed: 30348959google scholar: lookup
                  17. McGrath SE, Annels N, Madhuri TK, Tailor A, Butler-Manuel SA, Morgan R, Pandha H, Michael A. Engrailed-2 (EN2) - a novel biomarker in epithelial ovarian cancer. BMC Cancer 2018 Oct 3;18(1):943.
                    doi: 10.1186/s12885-018-4816-5pubmed: 30285763google scholar: lookup
                  18. Bothun AM, Woods DC. Dynamics of WNT signaling components in the human ovary from development to adulthood. Histochem Cell Biol 2019 Feb;151(2):115-123.
                    doi: 10.1007/s00418-018-1729-ypubmed: 30284608google scholar: lookup
                  19. Fang X, Ni N, Gao Y, Vincent DF, Bartholin L, Li Q. A novel mouse model of testicular granulosa cell tumors. Mol Hum Reprod 2018 Jul 1;24(7):343-356.
                    doi: 10.1093/molehr/gay023pubmed: 29788434google scholar: lookup
                  20. Patterson AL, Pirochta J, Tufano SY, Teixeira JM. Gain-of-function β-catenin in the uterine mesenchyme leads to impaired implantation and decidualization. J Endocrinol 2017 Apr;233(1):119-130.
                    doi: 10.1530/JOE-16-0502pubmed: 28183999google scholar: lookup
                  21. Fang X, Gao Y, Li Q. SMAD3 Activation: A Converging Point of Dysregulated TGF-Beta Superfamily Signaling and Genetic Aberrations in Granulosa Cell Tumor Development?. Biol Reprod 2016 Nov;95(5):105.
                    doi: 10.1095/biolreprod.116.143412pubmed: 27683263google scholar: lookup
                  22. Gao Y, Vincent DF, Davis AJ, Sansom OJ, Bartholin L, Li Q. Constitutively active transforming growth factor β receptor 1 in the mouse ovary promotes tumorigenesis. Oncotarget 2016 Jul 5;7(27):40904-40918.
                    doi: 10.18632/oncotarget.10149pubmed: 27344183google scholar: lookup
                  23. De Cian MC, Pauper E, Bandiera R, Vidal VP, Sacco S, Gregoire EP, Chassot AA, Panzolini C, Wilhelm D, Pailhoux E, Youssef SA, de Bruin A, Teerds K, Schedl A, Gillot I, Chaboissier MC. Amplification of R-spondin1 signaling induces granulosa cell fate defects and cancers in mouse adult ovary. Oncogene 2017 Jan 12;36(2):208-218.
                    doi: 10.1038/onc.2016.191pubmed: 27270435google scholar: lookup
                  24. Kumar M, Camlin NJ, Holt JE, Teixeira JM, McLaughlin EA, Tanwar PS. Germ cell specific overactivation of WNT/βcatenin signalling has no effect on folliculogenesis but causes fertility defects due to abnormal foetal development. Sci Rep 2016 Jun 6;6:27273.
                    doi: 10.1038/srep27273pubmed: 27265527google scholar: lookup
                  25. Kim SY. Insights into granulosa cell tumors using spontaneous or genetically engineered mouse models. Clin Exp Reprod Med 2016 Mar;43(1):1-8.
                    doi: 10.5653/cerm.2016.43.1.1pubmed: 27104151google scholar: lookup
                  26. Wang X, Khatri S, Broaddus R, Wang Z, Hawkins SM. Deletion of Arid1a in Reproductive Tract Mesenchymal Cells Reduces Fertility in Female Mice. Biol Reprod 2016 Apr;94(4):93.
                    doi: 10.1095/biolreprod.115.133637pubmed: 26962117google scholar: lookup
                  27. Rhee KJ, Lee JI, Eom YW. Mesenchymal Stem Cell-Mediated Effects of Tumor Support or Suppression. Int J Mol Sci 2015 Dec 16;16(12):30015-33.
                    doi: 10.3390/ijms161226215pubmed: 26694366google scholar: lookup
                  28. Hernandez Gifford JA. The role of WNT signaling in adult ovarian folliculogenesis. Reproduction 2015 Oct;150(4):R137-48.
                    doi: 10.1530/REP-14-0685pubmed: 26130815google scholar: lookup
                  29. Liu Z, Ren YA, Pangas SA, Adams J, Zhou W, Castrillon DH, Wilhelm D, Richards JS. FOXO1/3 and PTEN Depletion in Granulosa Cells Promotes Ovarian Granulosa Cell Tumor Development. Mol Endocrinol 2015 Jul;29(7):1006-24.
                    doi: 10.1210/me.2015-1103pubmed: 26061565google scholar: lookup
                  30. Pihlajoki M, Färkkilä A, Soini T, Heikinheimo M, Wilson DB. GATA factors in endocrine neoplasia. Mol Cell Endocrinol 2016 Feb 5;421:2-17.
                    doi: 10.1016/j.mce.2015.05.027pubmed: 26027919google scholar: lookup
                  31. Ribeiro JR, Freiman RN. Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer. J Steroid Biochem Mol Biol 2014 Sep;143:160-73.
                    doi: 10.1016/j.jsbmb.2014.02.010pubmed: 24565562google scholar: lookup
                  32. Stapp AD, Gómez BI, Gifford CA, Hallford DM, Hernandez Gifford JA. Canonical WNT signaling inhibits follicle stimulating hormone mediated steroidogenesis in primary cultures of rat granulosa cells. PLoS One 2014;9(1):e86432.
                    doi: 10.1371/journal.pone.0086432pubmed: 24466091google scholar: lookup
                  33. Fu D, Lv X, Hua G, He C, Dong J, Lele SM, Li DW, Zhai Q, Davis JS, Wang C. YAP regulates cell proliferation, migration, and steroidogenesis in adult granulosa cell tumors. Endocr Relat Cancer 2014 Apr;21(2):297-310.
                    doi: 10.1530/ERC-13-0339pubmed: 24389730google scholar: lookup
                  34. Morohaku K, Pelton SH, Daugherty DJ, Butler WR, Deng W, Selvaraj V. Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis. Endocrinology 2014 Jan;155(1):89-97.
                    doi: 10.1210/en.2013-1556pubmed: 24174323google scholar: lookup
                  35. Stewart CA, Wang Y, Bonilla-Claudio M, Martin JF, Gonzalez G, Taketo MM, Behringer RR. CTNNB1 in mesenchyme regulates epithelial cell differentiation during Müllerian duct and postnatal uterine development. Mol Endocrinol 2013 Sep;27(9):1442-54.
                    doi: 10.1210/me.2012-1126pubmed: 23904126google scholar: lookup
                  36. Dzafic E, Stimpfel M, Virant-Klun I. Plasticity of granulosa cells: on the crossroad of stemness and transdifferentiation potential. J Assist Reprod Genet 2013 Oct;30(10):1255-61.
                    doi: 10.1007/s10815-013-0068-0pubmed: 23893266google scholar: lookup
                  37. Law NC, Weck J, Kyriss B, Nilson JH, Hunzicker-Dunn M. Lhcgr expression in granulosa cells: roles for PKA-phosphorylated β-catenin, TCF3, and FOXO1. Mol Endocrinol 2013 Aug;27(8):1295-310.
                    doi: 10.1210/me.2013-1025pubmed: 23754802google scholar: lookup
                  38. Francis JC, Kolomeyevskaya N, Mach CM, Dietrich JE, Anderson ML. MicroRNAs and Recent Insights into Pediatric Ovarian Cancers. Front Oncol 2013;3:95.
                    doi: 10.3389/fonc.2013.00095pubmed: 23641362google scholar: lookup
                  39. Wang C, Lv X, Jiang C, Cordes CM, Fu L, Lele SM, Davis JS. Transforming growth factor alpha (TGFα) regulates granulosa cell tumor (GCT) cell proliferation and migration through activation of multiple pathways. PLoS One 2012;7(11):e48299.
                    doi: 10.1371/journal.pone.0048299pubmed: 23155381google scholar: lookup
                  40. Tanwar PS, Commandeur AE, Zhang L, Taketo MM, Teixeira JM. The Müllerian inhibiting substance type 2 receptor suppresses tumorigenesis in testes with sustained β-catenin signaling. Carcinogenesis 2012 Dec;33(12):2351-61.
                    doi: 10.1093/carcin/bgs281pubmed: 22962306google scholar: lookup
                  41. Laguë MN, Romieu-Mourez R, Bonneil É, Boyer A, Pouletty N, Mes-Masson AM, Thibault P, Nadeau MÈ, Boerboom D. Proteomic profiling of a mouse model for ovarian granulosa cell tumor identifies VCP as a highly sensitive serum tumor marker in several human cancers. PLoS One 2012;7(8):e42470.
                    doi: 10.1371/journal.pone.0042470pubmed: 22870330google scholar: lookup
                  42. Pangas SA. Regulation of the ovarian reserve by members of the transforming growth factor beta family. Mol Reprod Dev 2012 Oct;79(10):666-79.
                    doi: 10.1002/mrd.22076pubmed: 22847922google scholar: lookup
                  43. Mullany LK, Richards JS. Minireview: animal models and mechanisms of ovarian cancer development. Endocrinology 2012 Apr;153(4):1585-92.
                    doi: 10.1210/en.2011-2121pubmed: 22396450google scholar: lookup
                  44. Fan HY, Liu Z, Mullany LK, Richards JS. Consequences of RAS and MAPK activation in the ovary: the good, the bad and the ugly. Mol Cell Endocrinol 2012 Jun 5;356(1-2):74-9.
                    doi: 10.1016/j.mce.2011.12.005pubmed: 22197887google scholar: lookup
                  45. Nagashima T, Kim J, Li Q, Lydon JP, DeMayo FJ, Lyons KM, Matzuk MM. Connective tissue growth factor is required for normal follicle development and ovulation. Mol Endocrinol 2011 Oct;25(10):1740-59.
                    doi: 10.1210/me.2011-1045pubmed: 21868453google scholar: lookup
                  46. Richards JS, Fan HY, Liu Z, Tsoi M, Laguë MN, Boyer A, Boerboom D. Either Kras activation or Pten loss similarly enhance the dominant-stable CTNNB1-induced genetic program to promote granulosa cell tumor development in the ovary and testis. Oncogene 2012 Mar 22;31(12):1504-20.
                    doi: 10.1038/onc.2011.341pubmed: 21860425google scholar: lookup
                  47. Myers M, Tripurani SK, Middlebrook B, Economides AN, Canalis E, Pangas SA. Loss of gremlin delays primordial follicle assembly but does not affect female fertility in mice. Biol Reprod 2011 Dec;85(6):1175-82.
                    doi: 10.1095/biolreprod.111.091728pubmed: 21832168google scholar: lookup
                  48. Pangas SA. Bone morphogenetic protein signaling transcription factor (SMAD) function in granulosa cells. Mol Cell Endocrinol 2012 Jun 5;356(1-2):40-7.
                    doi: 10.1016/j.mce.2011.06.021pubmed: 21763749google scholar: lookup
                  49. Tanwar PS, Zhang L, Kaneko-Tarui T, Curley MD, Taketo MM, Rani P, Roberts DJ, Teixeira JM. Mammalian target of rapamycin is a therapeutic target for murine ovarian endometrioid adenocarcinomas with dysregulated Wnt/β-catenin and PTEN. PLoS One 2011;6(6):e20715.
                    doi: 10.1371/journal.pone.0020715pubmed: 21695255google scholar: lookup
                  50. Richards JS, Pangas SA. New insights into ovarian function. Handb Exp Pharmacol 2010;(198):3-27.
                    doi: 10.1007/978-3-642-02062-9_1pubmed: 20839083google scholar: lookup
                  51. Nagaraja AK, Middlebrook BS, Rajanahally S, Myers M, Li Q, Matzuk MM, Pangas SA. Defective gonadotropin-dependent ovarian folliculogenesis and granulosa cell gene expression in inhibin-deficient mice. Endocrinology 2010 Oct;151(10):4994-5006.
                    doi: 10.1210/en.2010-0428pubmed: 20739397google scholar: lookup
                  52. Fan HY, O'Connor A, Shitanaka M, Shimada M, Liu Z, Richards JS. Beta-catenin (CTNNB1) promotes preovulatory follicular development but represses LH-mediated ovulation and luteinization. Mol Endocrinol 2010 Aug;24(8):1529-42.
                    doi: 10.1210/me.2010-0141pubmed: 20610534google scholar: lookup
                  53. Boyer A, Lapointe E, Zheng X, Cowan RG, Li H, Quirk SM, DeMayo FJ, Richards JS, Boerboom D. WNT4 is required for normal ovarian follicle development and female fertility. FASEB J 2010 Aug;24(8):3010-25.
                    doi: 10.1096/fj.09-145789pubmed: 20371632google scholar: lookup
                  54. Richards JS, Pangas SA. The ovary: basic biology and clinical implications. J Clin Invest 2010 Apr;120(4):963-72.
                    doi: 10.1172/JCI41350pubmed: 20364094google scholar: lookup
                  55. Wang HX, Li TY, Kidder GM. WNT2 regulates DNA synthesis in mouse granulosa cells through beta-catenin. Biol Reprod 2010 May;82(5):865-75.
                    doi: 10.1095/biolreprod.109.080903pubmed: 20107203google scholar: lookup
                  56. Fan HY, Richards JS. Minireview: physiological and pathological actions of RAS in the ovary. Mol Endocrinol 2010 Feb;24(2):286-98.
                    doi: 10.1210/me.2009-0251pubmed: 19880654google scholar: lookup
                  57. Roy L, McDonald CA, Jiang C, Maroni D, Zeleznik AJ, Wyatt TA, Hou X, Davis JS. Convergence of 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A and glycogen synthase kinase-3beta/beta-catenin signaling in corpus luteum progesterone synthesis. Endocrinology 2009 Nov;150(11):5036-45.
                    doi: 10.1210/en.2009-0771pubmed: 19819952google scholar: lookup
                  58. Middlebrook BS, Eldin K, Li X, Shivasankaran S, Pangas SA. Smad1-Smad5 ovarian conditional knockout mice develop a disease profile similar to the juvenile form of human granulosa cell tumors. Endocrinology 2009 Dec;150(12):5208-17.
                    doi: 10.1210/en.2009-0644pubmed: 19819941google scholar: lookup
                  59. Fong MY, Kakar SS. Ovarian cancer mouse models: a summary of current models and their limitations. J Ovarian Res 2009 Sep 28;2(1):12.
                    doi: 10.1186/1757-2215-2-12pubmed: 19781107google scholar: lookup
                  60. Edson MA, Nagaraja AK, Matzuk MM. The mammalian ovary from genesis to revelation. Endocr Rev 2009 Oct;30(6):624-712.
                    doi: 10.1210/er.2009-0012pubmed: 19776209google scholar: lookup
                  61. Chang H, Guillou F, Taketo MM, Behringer RR. Overactive beta-catenin signaling causes testicular sertoli cell tumor development in the mouse. Biol Reprod 2009 Nov;81(5):842-9.
                    doi: 10.1095/biolreprod.109.077446pubmed: 19553598google scholar: lookup
                  62. Tanwar PS, Lee HJ, Zhang L, Zukerberg LR, Taketo MM, Rueda BR, Teixeira JM. Constitutive activation of Beta-catenin in uterine stroma and smooth muscle leads to the development of mesenchymal tumors in mice. Biol Reprod 2009 Sep;81(3):545-52.
                    doi: 10.1095/biolreprod.108.075648pubmed: 19403928google scholar: lookup
                  63. Boyer A, Paquet M, Laguë MN, Hermo L, Boerboom D. Dysregulation of WNT/CTNNB1 and PI3K/AKT signaling in testicular stromal cells causes granulosa cell tumor of the testis. Carcinogenesis 2009 May;30(5):869-78.
                    doi: 10.1093/carcin/bgp051pubmed: 19237610google scholar: lookup
                  64. Hernandez Gifford JA, Hunzicker-Dunn ME, Nilson JH. Conditional deletion of beta-catenin mediated by Amhr2cre in mice causes female infertility. Biol Reprod 2009 Jun;80(6):1282-92.
                    doi: 10.1095/biolreprod.108.072280pubmed: 19176883google scholar: lookup
                  65. Li Q, Pangas SA, Jorgez CJ, Graff JM, Weinstein M, Matzuk MM. Redundant roles of SMAD2 and SMAD3 in ovarian granulosa cells in vivo. Mol Cell Biol 2008 Dec;28(23):7001-11.
                    doi: 10.1128/MCB.00732-08pubmed: 18809571google scholar: lookup
                  66. Hong X, Luense LJ, McGinnis LK, Nothnick WB, Christenson LK. Dicer1 is essential for female fertility and normal development of the female reproductive system. Endocrinology 2008 Dec;149(12):6207-12.
                    doi: 10.1210/en.2008-0294pubmed: 18703631google scholar: lookup
                  67. Laguë MN, Paquet M, Fan HY, Kaartinen MJ, Chu S, Jamin SP, Behringer RR, Fuller PJ, Mitchell A, Doré M, Huneault LM, Richards JS, Boerboom D. Synergistic effects of Pten loss and WNT/CTNNB1 signaling pathway activation in ovarian granulosa cell tumor development and progression. Carcinogenesis 2008 Nov;29(11):2062-72.
                    doi: 10.1093/carcin/bgn186pubmed: 18687666google scholar: lookup
                  68. Maatouk DM, DiNapoli L, Alvers A, Parker KL, Taketo MM, Capel B. Stabilization of beta-catenin in XY gonads causes male-to-female sex-reversal. Hum Mol Genet 2008 Oct 1;17(19):2949-55.
                    doi: 10.1093/hmg/ddn193pubmed: 18617533google scholar: lookup
                  69. Fan HY, Shimada M, Liu Z, Cahill N, Noma N, Wu Y, Gossen J, Richards JS. Selective expression of KrasG12D in granulosa cells of the mouse ovary causes defects in follicle development and ovulation. Development 2008 Jun;135(12):2127-37.
                    doi: 10.1242/dev.020560pubmed: 18506027google scholar: lookup
                  70. Gatcliffe TA, Monk BJ, Planutis K, Holcombe RF. Wnt signaling in ovarian tumorigenesis. Int J Gynecol Cancer 2008 Sep-Oct;18(5):954-62.
                  71. Pangas SA, Li X, Umans L, Zwijsen A, Huylebroeck D, Gutierrez C, Wang D, Martin JF, Jamin SP, Behringer RR, Robertson EJ, Matzuk MM. Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice. Mol Cell Biol 2008 Jan;28(1):248-57.
                    doi: 10.1128/MCB.01404-07pubmed: 17967875google scholar: lookup
                  72. Parakh TN, Hernandez JA, Grammer JC, Weck J, Hunzicker-Dunn M, Zeleznik AJ, Nilson JH. Follicle-stimulating hormone/cAMP regulation of aromatase gene expression requires beta-catenin. Proc Natl Acad Sci U S A 2006 Aug 15;103(33):12435-40.
                    doi: 10.1073/pnas.0603006103pubmed: 16895991google scholar: lookup
                  73. Grisham RN, Hopp E, Pennington K, Holloway R, Wenham RM, Blecharz P, Dockery L, Matsuo K, Salani R, Bidzinski M, Braly P, Celano P, Reid T, Seward S, Lewis J, Johnson M, DuBose R, Ahn S, Cheng S, Alvero C, Konstantinopoulos PA. Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumours. Clin Transl Med 2026 Jan;16(1):e70568.
                    doi: 10.1002/ctm2.70568pubmed: 41518037google scholar: lookup
                  74. Li J, Welte T, Calzoncinth K, Vuttaradhi VK, Brodsky AL, Wong KK, Sebastian MM, Lawson B, Kingsley CV, Hillman RT. An inducible FOXL2-dependent mouse model of ovarian adult type granulosa cell tumor. Gynecol Oncol 2025 Mar;194:125-130.
                    doi: 10.1016/j.ygyno.2025.01.011pubmed: 40221170google scholar: lookup
                  75. Takase HM, Mishina T, Hayashi T, Yoshimura M, Kuse M, Nikaido I, Kitajima TS. Transcriptomic signatures of WNT-driven pathways and granulosa cell-oocyte interactions during primordial follicle activation. PLoS One 2024;19(10):e0311978.
                    doi: 10.1371/journal.pone.0311978pubmed: 39441825google scholar: lookup
                  76. Bérubé M, Abedini A, Lapointe E, Gusscott S, Brind'Amour J, Zamberlam G, Boerboom D. SFRP4 promotes autophagy and blunts FSH responsiveness through inhibition of AKT signaling in ovarian granulosa cells. Cell Commun Signal 2024 Aug 14;22(1):396.
                    doi: 10.1186/s12964-024-01736-1pubmed: 39138534google scholar: lookup
                  77. Dang W, Ren Y, Chen Q, He M, Kebreab E, Wang D, Lyu L. Notch2 Regulates the Function of Bovine Follicular Granulosa Cells via the Wnt2/β-Catenin Signaling Pathway. Animals (Basel) 2024 Mar 25;14(7).
                    doi: 10.3390/ani14071001pubmed: 38612240google scholar: lookup
                  78. Herman L, Amo A, Legois B, Di Carlo C, Veitia RA, Todeschini AL. A cellular model provides insights into the pathogenicity of the oncogenic FOXL2 somatic variant p.Cys134Trp. Br J Cancer 2024 May;130(9):1453-1462.
                    doi: 10.1038/s41416-024-02613-xpubmed: 38429437google scholar: lookup